S&P 500   4,536.19 (+0.37%)
DOW   35,609.34 (+0.43%)
QQQ   374.42 (-0.28%)
AAPL   149.16 (+0.27%)
MSFT   307.43 (-0.26%)
FB   340.60 (+0.18%)
GOOGL   2,831.55 (-1.16%)
TSLA   860.60 (-0.42%)
AMZN   3,411.10 (-0.96%)
NVDA   221.03 (-0.84%)
BABA   177.15 (+0.08%)
NIO   39.56 (-1.17%)
CGC   14.25 (-0.63%)
GE   105.95 (+1.16%)
AMD   116.28 (-0.04%)
MU   68.06 (+0.73%)
T   25.89 (+1.17%)
F   16.05 (+4.09%)
ACB   7.66 (+2.82%)
DIS   170.16 (-0.60%)
PFE   42.80 (+1.69%)
BA   216.23 (+0.12%)
AMC   40.83 (+0.07%)
S&P 500   4,536.19 (+0.37%)
DOW   35,609.34 (+0.43%)
QQQ   374.42 (-0.28%)
AAPL   149.16 (+0.27%)
MSFT   307.43 (-0.26%)
FB   340.60 (+0.18%)
GOOGL   2,831.55 (-1.16%)
TSLA   860.60 (-0.42%)
AMZN   3,411.10 (-0.96%)
NVDA   221.03 (-0.84%)
BABA   177.15 (+0.08%)
NIO   39.56 (-1.17%)
CGC   14.25 (-0.63%)
GE   105.95 (+1.16%)
AMD   116.28 (-0.04%)
MU   68.06 (+0.73%)
T   25.89 (+1.17%)
F   16.05 (+4.09%)
ACB   7.66 (+2.82%)
DIS   170.16 (-0.60%)
PFE   42.80 (+1.69%)
BA   216.23 (+0.12%)
AMC   40.83 (+0.07%)
S&P 500   4,536.19 (+0.37%)
DOW   35,609.34 (+0.43%)
QQQ   374.42 (-0.28%)
AAPL   149.16 (+0.27%)
MSFT   307.43 (-0.26%)
FB   340.60 (+0.18%)
GOOGL   2,831.55 (-1.16%)
TSLA   860.60 (-0.42%)
AMZN   3,411.10 (-0.96%)
NVDA   221.03 (-0.84%)
BABA   177.15 (+0.08%)
NIO   39.56 (-1.17%)
CGC   14.25 (-0.63%)
GE   105.95 (+1.16%)
AMD   116.28 (-0.04%)
MU   68.06 (+0.73%)
T   25.89 (+1.17%)
F   16.05 (+4.09%)
ACB   7.66 (+2.82%)
DIS   170.16 (-0.60%)
PFE   42.80 (+1.69%)
BA   216.23 (+0.12%)
AMC   40.83 (+0.07%)
S&P 500   4,536.19 (+0.37%)
DOW   35,609.34 (+0.43%)
QQQ   374.42 (-0.28%)
AAPL   149.16 (+0.27%)
MSFT   307.43 (-0.26%)
FB   340.60 (+0.18%)
GOOGL   2,831.55 (-1.16%)
TSLA   860.60 (-0.42%)
AMZN   3,411.10 (-0.96%)
NVDA   221.03 (-0.84%)
BABA   177.15 (+0.08%)
NIO   39.56 (-1.17%)
CGC   14.25 (-0.63%)
GE   105.95 (+1.16%)
AMD   116.28 (-0.04%)
MU   68.06 (+0.73%)
T   25.89 (+1.17%)
F   16.05 (+4.09%)
ACB   7.66 (+2.82%)
DIS   170.16 (-0.60%)
PFE   42.80 (+1.69%)
BA   216.23 (+0.12%)
AMC   40.83 (+0.07%)
NYSEARCA:ARKG

ARK Genomic Revolution Multi-Sector ETF Stock Forecast, Price & News

$75.63
-0.71 (-0.93 %)
(As of 10/20/2021 04:00 PM ET)
Add
Today's Range
$75.48
$76.70
50-Day Range
$71.39
$87.88
52-Week Range
$64.33
$115.15
Volume649,379 shs
Average Volume3.55 million shs
Market Capitalization$7.14 billion
P/E RatioN/A
Dividend Yield1.07%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ARKG News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution Multi-Sector ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ARK
Fund NameARK Genomic Revolution Multi-Sector ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:ARKG
Inception Date10/30/2014
Fund ManagerCatherine D. Wood
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNot Applicable
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$7.22 billion
Average Daily Volume$2.21 million
Discount/Premium-0.07%

ETF Expenses

Management Fee0.75%
Other Expenses0.00%
Total Expenses0.75%
Fee Waiver0.00%
Net Expenses0.75%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorARK Investment Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerJane Street

Geographic Exposure of ARKG

Currency Exposure of ARKG

Sector Exposure of ARKG

Industry Exposure of ARKG













ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG) Frequently Asked Questions

What stocks does MarketBeat like better than ARK Genomic Revolution Multi-Sector ETF?

Wall Street analysts have given ARK Genomic Revolution Multi-Sector ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ARK Genomic Revolution Multi-Sector ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ARK Genomic Revolution Multi-Sector ETF's stock price been impacted by COVID-19 (Coronavirus)?

ARK Genomic Revolution Multi-Sector ETF's stock was trading at $32.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ARKG shares have increased by 135.7% and is now trading at $75.77.
View which stocks have been most impacted by COVID-19
.

Is ARK Genomic Revolution Multi-Sector ETF a good dividend stock?

ARK Genomic Revolution Multi-Sector ETF pays an annual dividend of $0.79 per share and currently has a dividend yield of 1.07%.
View ARK Genomic Revolution Multi-Sector ETF's dividend history.

What other stocks do shareholders of ARK Genomic Revolution Multi-Sector ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARK Genomic Revolution Multi-Sector ETF investors own include Tesla (TSLA), ARK Innovation ETF (ARKK), NVIDIA (NVDA), ARK Next Generation Internation ETF (ARKW), Alibaba Group (BABA), Intel (INTC), PayPal (PYPL), Alphabet (GOOG), Netflix (NFLX) and Square (SQ).

What is ARK Genomic Revolution Multi-Sector ETF's stock symbol?

ARK Genomic Revolution Multi-Sector ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ARKG."

Who are ARK Genomic Revolution Multi-Sector ETF's major shareholders?

ARK Genomic Revolution Multi-Sector ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Carroll Financial Associates Inc. (0.31%), SOA Wealth Advisors LLC. (0.08%), Arkadios Wealth Advisors (0.04%), IFP Advisors Inc (0.02%), Archford Capital Strategies LLC (0.01%) and IFG Advisory LLC (0.00%).

Which institutional investors are selling ARK Genomic Revolution Multi-Sector ETF stock?

ARKG stock was sold by a variety of institutional investors in the last quarter, including Arkadios Wealth Advisors, SOA Wealth Advisors LLC., Red Door Wealth Management LLC, AdvisorNet Financial Inc, Avondale Wealth Management, and Advocacy Wealth Management Services LLC.

Which institutional investors are buying ARK Genomic Revolution Multi-Sector ETF stock?

ARKG stock was bought by a variety of institutional investors in the last quarter, including IFP Advisors Inc, Carroll Financial Associates Inc., IFG Advisory LLC, Creative Financial Designs Inc. ADV, Archford Capital Strategies LLC, and Asset Dedication LLC.

How do I buy shares of ARK Genomic Revolution Multi-Sector ETF?

Shares of ARKG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ARK Genomic Revolution Multi-Sector ETF's stock price today?

One share of ARKG stock can currently be purchased for approximately $75.77.

How much money does ARK Genomic Revolution Multi-Sector ETF make?

ARK Genomic Revolution Multi-Sector ETF has a market capitalization of $7.16 billion.


This page was last updated on 10/20/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.